Improving access to blood cancer clinical trials | Dana-Farber Cancer Institute
80 views · Published 13 March 2017 · 1:16 · Indexed 24 October 2026
Channel: Dana-Farber Cancer Institute · 2017 · Science & Technology
The Blood Cancer Research Partnership was developed by Dana-Farber Cancer Institute and the Leukemia and Lymphoma Society so that more patients with blood cancers can participate in early-stage, cutting-edge clinical trials. Robert Soiffer, Chief of the Division of Hematologic Malignancies at Dana-Farber describes how this network of community practices increases access to clinical trials evaluating new therapies for blood cancers. Learn more about the Blood Cancer Research Partnership.
More from this channel
-
0:18
Importance of Joining the Stem Cell Registry | Dana-Farber Cancer Institute
-
0:20
How to Join the Stem Cell Registry | Dana-Farber Cancer Institute
-
0:18
How to Register as a Stem Cell Donor | Dana-Farber Cancer Institute
-
3:03
Sportscaster Jim Britt for the Jimmy Fund | Dana-Farber Cancer Institute
-
0:07
Dana-Farber Banners | Dana-Farber Cancer Institute
-
2:08
Barbers for the Jimmy Fund | Dana-Farber Cancer Institute
-
1:43
Pets | Dana-Farber Cancer Institute
-
1:34
Healthy Eating for the Holiday Season | Dana-Farber Cancer Institute